Venous in Biological Technology

Medical Simulation Corporation to Introduce Central Line Management Program at the National Teaching Institute and Critical Care Exposition

... brings together the best practices for central venous catheter insertion and management into a ... physicians and providers to practice central venous access using SonoSite(R) ultrasound technology and a central venous trainer. MSC has selected SonoSite, Inc. as its ...

The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment

... of the Outcomes after Hospitalization for Deep venous Thrombosis or Pulmonary Embolism. 2002; 88:407-14. (4) Gerotziafas GT, Samama MM. Prophylaxis of venous thromboembolism medical patients. CurrOpin ... WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: The Seventh ACCP Conference on ...

Gift Aids Professor's Research into Vein Treatment

... endovenous device used in the treatment of venous reflux , the major underlying cause of varicose ... a student project concerning treatment of venous disease with our radiofrequency catheters, I ... devices for the minimally invasive treatment of venous reflux disease, a progressive condition that ...

VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007

... devices for the minimally invasive treatment of venous disease, today announced its financial results ... catheter is the preferred treatment for venous reflux. Furthermore, with third quarter operating ... devices for the minimally invasive treatment of venous reflux, a progressive condition caused ...

Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL(R) D-Dimer Assay

... -Now for Exclusion of venous Thromboembolism- LEXINGTON, Mass., Aug. 28 ... use for the HemosIL D-Dimer assay to exclude venous thromboembolism (VTE) in outpatients suspected of deep venous thrombosis (DVT) and pulmonary embolism (PE), ...

Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children

... could lead to a paradigm shift in the approach to venous access procedures such as drawing blood and ... comfort when performing the numerous peripheral venous access procedures that occur each day. Zingo will ... served in these hospitals undergo peripheral venous access procedures repeatedly, and are ...

FDA Accepts Zingo(TM) Supplemental New Drug Application to Reduce Pain Associated With Peripheral Needle Insertion Procedures in Adults

... to adults who experience pain upon peripheral venous access procedures, not only in the United States but also worldwide." venous access procedures, like IV insertions and blood ... In 2004, more than 245 million adult peripheral venous access procedures and more than 18 ...

Anesiva Announces First Quarter 2008 Financial Results

... There are approximately 18 million peripheral venous access procedures in children in U.S. hospitals ... approximately 245 million adult peripheral venous access procedures performed annually. -- In ... the use of a fast-acting TLA for peripheral venous access procedures. The results of the survey, ...

Skin & Aging Article Finds Derma Sciences MEDIHONEY(TM) Helps to Promote Healing Where Antibiotics Fail

... wounds (pressure ulcers, diabetic ulcers, and venous ulcers) showed that wounds treated more ... study on healing rates of 71 non-healing venous leg ulcers showed that none of the patients ... study showed that 44% of the non-healing venous leg ulcers treated with Active Leptospermum ...

VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales

... devices for the minimally invasive treatment of venous disease, today announced its financial results ... is emerging as the preferred treatment for venous reflux," said VNUS President and Chief Executive ... of peripheral vascular disease, including venous reflux, a progressive condition caused by ...

Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults

... for adults concerned about pain associated with venous access procedures." Peripheral venous access procedures are among the most ... the reduction of pain associated with peripheral venous access procedures in children ages three to 18. ...

Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook

... two initiatives aimed to improve peripheral venous access pain management in children: RN VOICE ... by nurses to facilitate better management of venous access pain; and ... providers seeking to better manage peripheral venous access pain in children. -- Proceeded with ...

Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers

... of patients with diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs) in the U.S. and around the ... targeting diabetics and others prone to chronic venous leg ulcers and diabetic foot ulcers. The campaign ... to heal, and a more active approach is needed." venous leg ulcers and diabetic foot ulcers are among the ...

The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis

... Day for the Evaluation of Patients at Risk for venous Thromboembolism in the Acute Hospital Care ... in medical patient." About venous thromboembolism (VTE) venous thromboembolism is a general term used to ...

Clexane(R)/Lovenox(R) Approved in Japan

... Health, Labour and Welfare for the prevention of venous thromboembolism (VTE) in patients undergoing ... knee replacement and hip fracture surgery. venous thromboembolism is a frequent and preventable ... to greatly contribute to the prevention of venous thromboembolism and fulfil an important medical ...

Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)

... system, to reduce pain associated with peripheral venous access procedures in children three to 18 years ... for the Reduction of Pain Associated with venous Access Procedures in Children Three to 18 Years ... system, to reduce pain associated with peripheral venous access procedures in children three to 18 years ...

Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals

... (FDA) to reduce the pain associated with venous access procedures, such as IV insertions or blood ... an important advantage over current options. venous access procedures, like IV insertions and blood ... a hospital, with more than 18 million pediatric venous access procedures and 400 million ...

Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial

... 5-Fluorouracil-coated (5-FU) Central venous Catheter (CVC). "After reviewing the data from ... 5-FU CVC product line in 2008. About Central venous Catheters (CVC) Central venous catheters (CVC) are usually inserted into ...

ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402

... which is being developed for the prevention of venous thromboembolic disorders (VTE - blood clots). ... unmet need. Prevention and Treatment of venous Thromboembolic disease (VTE) venous thromboembolic disease (deep vein thrombosis ...

Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children

... analgesia to reduce the pain associated with venous access procedures, such as IV insertions or blood ... the use of topical anesthetics prior to venous access procedures, currently available local ... call for the use of topical anesthetics prior to venous access procedures. "Healthcare providers have ...

Video: Varicose Veins, Much More Than a Cosmetic Issue, Can Prove a Health Risk

... spectrum of vein abnormalities, including varicose veins, spider veins, venous leg ulcers, facial veins, hand veins, Klippel-Trenaunay Syndrome and Restless Legs Syndrome resulting from venous reflux. VCA is a wholly-owned subsidiary of IntegraMed America, Inc, the ...

Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

... Perisurgery: PROCRIT (Epoetin alfa) increased the rate of deep venous thromboses in patients not receiving prophylactic anticoagulation. Consider deep venous thrombosis prophylaxis. Contraindications ...

VNUS Medical Technologies to Present at Piper Jaffray 20th Annual Healthcare Conference

... provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the Piper Jaffray ... provider of medical devices for the minimally invasive treatment of venous reflux, a progressive condition caused by incompetent vein valves in the ...

VNUS Medical Technologies, Inc. Announces the Hiring of Guido Smeets, MD, as Vice President of Clinical Research and Chief Medical Officer

... provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced the hiring of Guido Smeets, MD, as Vice ... provider of medical devices for the minimally invasive treatment of venous reflux, a progressive condition caused by incompetent vein valves in the ...

Glycotex Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing

... versus combined placebo and standard care in patients with chronic venous ulcers. The results provided proof-of concept and dose-ranging information ... wound healing following laser ablation, burn wounds, surgical wounds, venous ulcers and diabetic ulcers. About Glycotex, Inc. Glycotex, Inc. is a ....

Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer

... with Zingo on the U.S. market for treating pain associated with peripheral venous access procedures in children, and Adlea advancing in clinical ... available in the U.S. for the reduction of pain associated with peripheral venous access procedures in children ages three to 18. For full Zingo prescribing ...

Anesiva Announces Second Quarter 2008 Financial Results and Update

... training sessions for selected healthcare providers to advocate for better venous access pain management for their pediatric patients, to grow membership in ... available in the U.S. for the reduction of pain associated with peripheral venous access procedures in children ages three to 18. For full Zingo prescribing ...

Chest Physicians Now Suggest Early Intervention for Certain Blood Clots in DVT

... past president of the Society of Interventional Radiology (SIR). The new venous Thromboembolic (VTE) Disease guidelines represent an evolution from the ... it often fails to clear the blockage. This residual thrombus can lead to venous hypertension, valvular insufficiency, skin ulcerations and post-thrombotic ...

VNUS Medical Technologies to Present at BMO Capital Markets 2008 Focus on Healthcare Conference

... provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the BMO Capital ... provider of medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that is often the underlying cause ...

EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board

... collective expertise of our Scientific Advisory Board in diabetic foot, venous and pressure ulcers, biotechnology, clinical development and wound ... designed to treat all forms of chronic wounds including diabetic ulcers, venous ulcers and pressure ulcers. DermaStream touch-free treatments result in ...

Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008

... several new products at AATS: -- Edwards is offering new arterial and venous cannulae, which are the flexible tubes used to establish ... challenging surgical approach. Among these are the FemTrak femoral venous cannula and the OptiSite arterial cannula, which both have proprietary ...

Anesiva Announces Expansion of Zingo Agreement in Europe

... Zingo to provide quick-onset, needle-free analgesia prior to peripheral venous access procedures in children," said Samantha R. Miller, Anesiva's vice ... product, Zingo(TM), for the reduction of pain associated with peripheral venous access procedures in children ages three to 18. The second product in ...

Anesiva Announces New Zingo Marketing and Distribution Agreement

... local analgesic with a rapid onset of action, prior to peripheral venous access procedures in children, and is further validation of the unmet need ... product, Zingo(TM), for the reduction of pain associated with peripheral venous access procedures in children ages three to 18. The second product in ...

Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa)

... a chemotherapy course. Perisurgery: PROCRIT(R) increased the rate of deep venous thromboses in patients not receiving prophylactic anticoagulation. ... a chemotherapy course. Perisurgery: PROCRIT(R) increased the rate of deep venous thromboses in patients not receiving prophylactic anticoagulation. ...

Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC

... launching the commercial 5-FU CVC product line in 2008. About Central venous Catheters (CVC) and Catheter-Related Infections Central venous catheters (CVC) are usually inserted into critically ill patients for ...

ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting

... would fill a significant unmet need. Prevention and Treatment of venous Thromboembolic disease (VTE) venous thromboembolic disease (deep vein thrombosis (DVT), pulmonary embolism) ...

Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) Label Reflects Recommendations from Recent FDA Advisory Committee Meetings

... a chemotherapy course. Perisurgery: PROCRIT(R) increased the rate of deep venous thromboses in patients not receiving prophylactic anticoagulation. ... of a chemotherapy course. Perisurgery: PROCRIT increased the rate of deep venous thromboses in patients not receiving prophylactic anticoagulation. ...

Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use for HemosIL(R) D-Dimer HS Assay

... - Now for Exclusion of venous Thromboembolism - LEXINGTON, Mass., Oct. 9 /PRNewswire/ -- ... clearance to expand the intended use for HemosIL D-Dimer HS to exclude venous thromboembolism (VTE) in outpatients suspected of deep vein thrombosis ...

Ortho Biotech Supports FDA Advisory Committees' Recommendations on Use of ESAs in Chronic Renal Failure Patients

... and for serious cardiovascular events (including serious arterial and venous thromboembolic events, myocardial infarction, stroke, congestive heart ... reduction of allogeneic RBC transfusions: A higher incidence of deep venous thrombosis was documented in patients receiving PROCRIT who were not ...

New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome

... to its antithrombotic properties. It is used to inhibit clot formation in venous and arterial vessels to prevent potential acute or chronic complications of venous or arterial thrombosis. As with all anticoagulants, the most frequently ...